Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up

被引:4
|
作者
Tang, Jiyang [1 ,2 ,3 ,4 ]
Han, Xinyao [1 ,2 ,3 ,4 ]
Tang, Ran [1 ,2 ,3 ,4 ]
Li, Mengyang [1 ,2 ,3 ,4 ]
Wang, Zongyi [1 ,2 ,3 ,4 ]
Zhao, Mingwei [1 ,2 ,3 ,4 ]
Qu, Jinfeng [1 ,2 ,3 ,4 ]
机构
[1] Peking Univ Peoples Hosp, Dept Ophthalmol, 11 Xizhimen South St, Beijing 100044, Peoples R China
[2] Eye Dis & Optometry Inst, Beijing, Peoples R China
[3] Beijing Key Lab Diag & Therapy Retinal & Choroid, Beijing, Peoples R China
[4] Peking Univ, Hlth Sci Ctr, Coll Optometry, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Pachychoroid; Pachychoroid pigment epitheliopathy; Polypoidal choroidal vasculopathy; Pachychoroid spectrum diseases; NEOVASCULARIZATION; ANGIOGRAPHY;
D O I
10.1186/s12886-022-02487-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Pachychoroid pigment epitheliopathy (PPE), a retinal disorder that falls into the pachychoroid spectrum, is characterized by retinal pigment epithelium changes in pachychoroid eyes without existing or previous subretinal fluid or soft drusen. Previous reports have indicated that PPE may share some pathophysiologic component with other pachychoroid spectrum diseases and could transform into central serous chorioretinopathy (CSC) during follow-up. CSC transformation to PNV and PCV has also been reported, but PPE transformation to PCV has not been reported. Case presentation Seven eyes of seven patients (four male three female, aged 62.7 +/- 8.4 years) who presented with PPE at baseline transformed to PCV during follow-up. All study eyes had baseline contralateral eye diagnoses of PCV. All PPE eyes reported no symptoms at baseline and were followed up regularly for the treatment of their contralateral eyes. All PPE presented as pigment epithelium detachment (PED) at baseline. The mean central macular thickness (CMT) was 217.6 +/- 14.6 mu m, the mean subfoveal choroidal thickness (SFCT) was 354.9 +/- 94.9 mu m, and the mean sub-PPE choroidal thickness was 332.3 +/- 84.6 mu m. The mean PPE width and height were 1326.4 +/- 791.4 mu m and 58.7 +/- 23.6 mu m, respectively, at baseline. Disruption of the ellipsoid zone (EZ) was noted in 3 eyes, while choroidal vascular hyperpermeability (CVH) was noted in 5 eyes at baseline. The follow-up period was 75.0 +/- 41.1 months, and the mean transformation time was 49.6 +/- 24.8 months. All study eyes received no intervention before transformation. Conclusions PPE could transform to PCV after a long follow-up period. Regular follow-ups for a long time should be recommended for patients with PPE.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up
    Jiyang Tang
    Xinyao Han
    Ran Tang
    Mengyang Li
    Zongyi Wang
    Mingwei Zhao
    Jinfeng Qu
    BMC Ophthalmology, 22
  • [2] Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics
    Murat Karacorlu
    M. Giray Ersoz
    Serra Arf
    Mumin Hocaoglu
    Isil Sayman Muslubas
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 2319 - 2326
  • [3] Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics
    Karacorlu, Murat
    Ersoz, M. Giray
    Arf, Serra
    Hocaoglu, Mumin
    Muslubas, Isil Sayman
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (12) : 2319 - 2326
  • [4] Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin
    Sayanagi, Kaori
    Gomi, Fumi
    Sawa, Miki
    Ohji, Masahito
    Tano, Yasuo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (10) : 1569 - 1571
  • [5] Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin
    Kaori Sayanagi
    Fumi Gomi
    Miki Sawa
    Masahito Ohji
    Yasuo Tano
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1569 - 1571
  • [6] Polypoidal Choroidal Vasculopathy after Stereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: A Case Report with Long-Term Follow-Up
    Steinemann, Alexandra
    Hoffmann, Laura
    Hatz, Katja B.
    CASE REPORTS IN OPHTHALMOLOGY, 2021, 12 (01): : 299 - 305
  • [7] PHOTODYNAMIC THERAPY WITH VERTEPORFIN IN POLYPOIDAL CHOROIDAL VASCULOPATHY Results After 3 Years of Follow-Up
    Leal, Sergio
    Silva, Rufino
    Figueira, Joao
    Luz Cachulo, M.
    Pires, Isabel
    Faria de Abreu, Jose Rui
    Cunha-Vaz, Jose Guilherme
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (08): : 1197 - 1205
  • [8] Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy
    Akaza, Eriko
    Yuzawa, Mitsuko
    Mori, Ryusaburo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2011, 55 (01) : 39 - 44
  • [9] Long-term cults of photodynamic therapy of polypoidal choroidal vasculopathy
    Akaza, Eriko
    Mori, Ryusaburo
    Yuzawa, Mitsuko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (05): : 717 - 722
  • [10] Long-Term Prognosis of Patients with Polypoidal Choroidal Vasculopathy Treated with Photodynamic Therapy
    Sakaeda, Yukinori
    Kato, Aki
    Kuwayama, Soichiro
    Hirahara, Shuichiro
    Suzuki, Norihiro
    Ogura, Yuichiro
    Nakazawa, Yoko
    Yasukawa, Tsutomu
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)